Skip to content

Vericel VCEL Net Change in Cash

Net Change in Cash at other companies

Stryker logo
StrykerSYK
-$1.13B+14.9%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
-$167.7M-120%
LeMaitre Vascular logo
LeMaitre VascularLMAT
-$1.39M-416%
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
-$182.43M-1,142%
Globus Medical logo
Globus MedicalGMED
$34.79M+111%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.98B-86.2%

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.13B-26.8%

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's net change in cash?
Vericel (VCEL) reported net change in cash of $9.2M in Q1 2026.
How has Vericel's net change in cash changed year-over-year?
Vericel's net change in cash increased by 272.2% year-over-year, from -$5.34M to $9.2M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.